Go Prime
Novo Nordisk Announces Major Insulin Price Cut by Up to 75%, Following in the Footsteps of Eli Lilly
2023-03-15
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
2022-10-20
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
How Governments Around the World Should Respond to the Mounting Costs of Gene and Cell Therapy?
2022-07-08
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19